Tvardi Therapeutics (TVRD) EBT Margin (2013 - 2025)
Tvardi Therapeutics' EBT Margin was -158.78% in Q1 2025, up 1230.73 percentage points from -1389.51% a year earlier and up 574.56 percentage points from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) EBT Margin (2013 - 2025) Analysis & Trends
On a trailing twelve-month basis, Tvardi Therapeutics' EBT Margin was -359.75% through Mar 31, 2025, up 369.44 percentage points year-over-year; for FY2024, it was -998.53%, down 433.32 percentage points from FY2023.
- EBT Margin shows a five-year change of -459.51 percentage points (FY2019 to FY2024).
- In earlier years, EBT Margin was -565.21% in FY2023 (-361.05 pp), -204.16% in FY2022 (+179.90 pp), -384.06% in FY2021 (-389.77 pp) and 5.71% in FY2020 (+544.73 pp).
- The Q1 2025 figure marks the highest quarterly EBT Margin since Q2 2022.
- Compared with a year earlier, EBT Margin has increased for three straight quarters, with an average year-over-year change of -20.39 percentage points over the last eight quarters.
- The best year-over-year quarter for EBT Margin over five years was Q4 2022 (a gain of 3105.97 percentage points); the worst was Q4 2021 (a drop of 4136.19 percentage points).
- Per Business Quant data, TVRD's EBT Margin in the three quarters before Q1 2025 was -733.33% (Q4 2024), -215.69% (Q3 2024) and -703.83% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Tvardi Therapeutics | 12.48 Mn | 12.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -158.78% |
| Dec 31, 2024 | -733.33% |
| Sep 30, 2024 | -215.69% |
| Jun 30, 2024 | -703.83% |
| Mar 31, 2024 | -1,389.51% |
| Dec 31, 2023 | -1,085.45% |
| Sep 30, 2023 | -593.88% |
| Jun 30, 2023 | -466.46% |
| Mar 31, 2023 | -448.50% |
| Dec 31, 2022 | -960.04% |
| Sep 30, 2022 | -220.52% |
| Jun 30, 2022 | -19.44% |
| Mar 31, 2022 | -582.69% |
| Dec 31, 2021 | -4,066.02% |
| Sep 30, 2021 | -5.00% |
| Mar 31, 2021 | -1,204.19% |
| Dec 31, 2020 | 70.17% |
| Sep 30, 2020 | -179.59% |
| Jun 30, 2020 | -448.17% |
| Mar 31, 2020 | -358.88% |
API Access
Tvardi Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();